Review Article: An Adipocentric View of the Metabolic Syndrome and Cardiovascular Disease

被引:2
|
作者
Dennedy M.C. [1 ,3 ]
Vidal-Puig A. [1 ,2 ]
机构
[1] Department of Clinical Biochemistry, University of Cambridge Metabolic Research Laboratories, Level 4, MRC / Wellcome Trust Institute of Metabolic Science, Cambridge, CB2 0QQ, Box 289, Addenbrooke's Hospital
[2] Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge
[3] National University of Ireland and Galway University Hospital, c/o Discipline of Clinical Pharmacology and Therapeutics, Clinical Sciences Institute, National University of Ireland, Galway, Galway, Newcastle Road
关键词
Adipose Tissue; Cardiovascular; Lipotoxicity; Metabolic Syndrome; Obesity;
D O I
10.1007/s12170-014-0379-4
中图分类号
学科分类号
摘要
Dysfunctional adipose tissue impairs whole body lipid buffering, influencing the storage of lipids as well as their use as an energy source. Ectopic deposition of lipids within metabolic tissues arises as a result of adipose tissue dysfunction and the ensuing systemic lipotoxicity explains much of the pathogenesis underlying insulin resistance and cardiometabolic disease. Adipose tissue dysfunction appears to be a multifactorial, maladaptive response to a lipid-rich, high calorie diet which involves the interplay between adipocyte precursors, adipocytes, immune cells, lipoprotein carriers and metabolically active tissues. Understanding these interactions and unravelling the adipocentric nature of cardiometabolic complications relating to obesity is a major priority towards addressing the worldwide obesity pandemic and its costly complications. © 2014 Springer Science+Business Media New York.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 50 条
  • [1] Review article: the metabolic syndrome - a chronic cardiovascular inflammatory condition
    Zambon, A
    Pauletto, P
    Crepaldi, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 : 20 - 23
  • [2] Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view
    Wilson, PWF
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2004, 33 (03) : 467 - +
  • [3] Oxidative Stress and Metabolic Pathologies: From an Adipocentric Point of View
    Le Lay, Soazig
    Simard, Gilles
    Martinez, Maria Carmen
    Andriantsitohaina, Ramaroson
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [4] Metabolic syndrome and cardiovascular disease
    Qiao, Qing
    Gao, Weiguo
    Zhang, Lei
    Nyamdorj, Regzedmaa
    Tuomilehto, Jaakko
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 : 232 - 263
  • [5] The metabolic syndrome and cardiovascular disease
    Vitarius, JA
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (04): : 257 - 262
  • [6] The metabolic syndrome and cardiovascular disease
    Bonora, E
    [J]. ANNALS OF MEDICINE, 2006, 38 (01) : 64 - 80
  • [7] Review article: the treatment of fatty liver disease associated with the metabolic syndrome
    Marchesini, G
    Natale, S
    Manini, R
    Agostini, F
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 : 37 - 39
  • [8] Magnesium in Hypertension, Cardiovascular Disease, Metabolic Syndrome, and Other Conditions: A Review
    Champagne, Catherine M.
    [J]. NUTRITION IN CLINICAL PRACTICE, 2008, 23 (02) : 142 - 151
  • [9] Renal disease, the metabolic syndrome, and cardiovascular disease
    Hoy, Wendy E.
    Kondalsamy-Chennakesavan, Srinivas
    McDonald, Stephen
    Wang, Zhiqiang
    [J]. ETHNICITY & DISEASE, 2006, 16 (02) : 46 - 51
  • [10] Review article: the metabolic syndrome and non-alcoholic fatty liver disease
    Loria, P
    Lonardot, A
    Carulli, L
    Verrone, AM
    Ricchi, M
    Lombardini, S
    Rudilosso, A
    Ballestri, S
    Carulli, N
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 : 31 - 36